scispace - formally typeset
A

Anne Dubart-Kupperschmitt

Researcher at French Institute of Health and Medical Research

Publications -  59
Citations -  2689

Anne Dubart-Kupperschmitt is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Induced pluripotent stem cell & Stem cell. The author has an hindex of 23, co-authored 56 publications receiving 2444 citations. Previous affiliations of Anne Dubart-Kupperschmitt include Centre national de la recherche scientifique & University of Paris.

Papers
More filters
Journal ArticleDOI

Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein.

TL;DR: This method provides a basis for developing cell therapy strategies using expanded HSCs that are not genetically modified and takes advantage of the ability of HOX proteins to passively translocate through cell membranes to eliminate any deleterious effects.
Journal ArticleDOI

The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells.

TL;DR: The reinsertion of the DNA flap sequence in an HIV-derived lentiviral vector promotes a striking increase of gene transduction efficiency in human CD34+ hematopoietic cells, and the complementation of the nuclear import defect present in the parental vector accounts for this result.
Journal ArticleDOI

Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells

TL;DR: A robust and efficient method for differentiating pluripotent stem cells into cholangiocyte‐like cells, which display structural and functional similarities to bile duct cells in normal liver, is developed.
Journal ArticleDOI

Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors

TL;DR: An HIV-derived lentiviral vector is presented, TRIPDeltaU3-EF1alpha, which can very efficiently transduce human cord blood HSC and results in high long-term transgene expression in CD34(+)-derived T, B, NK, and myeloid hematopoietic cells.